Beijing Diagreat Biotechnologies Co., Ltd of Beijing at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Manufacturers Trader

Beijing Diagreat Biotechnologies Co., Ltd

3rd Floor, Xinhualian Science&Technology Building, No. 5 Jiachuang Road, Tongzhou, 101111 Beijing
China
Telephone +86-10-69502385
Fax +86-10-65907615
zhengliceng@diagreat.com

This company is co-exhibitor of
Messe Duesseldorf China Ltd.

Hall map

MEDICA 2019 hall map (Hall 3): stand G92

Fairground map

MEDICA 2019 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.02  Diagnostic rapid tests

Our products

Product category: Diagnostic rapid tests

Multiple Channels TRFIA POCT Analyzer-D20

Convenient: Peripheral blood, serum, plasma available

Cost-effective, Get results in 10s

Accurate, Reliable and Easy operating

More Less

Product category: Diagnostic rapid tests

Single Chanel TRFIA POCT Analyzer-D10

Point-Of-Care-Test (POCT) System

Time-Resolved Fluorescence (TRF) is a kind of isotope optical markers. Compared with ordinary Fluorescence, it has a bigger Stock displacement and longer life.

It can effectively avoid the background fluorescence in the samples, and the influence of light and stray light, so compared to common fluorescence it has higher sensitivity and anti-interference ability.

More Less

Product category: Diagnostic rapid tests

Plumbum Determination Kit

Beijing Diagreat Biotech recently developed the heavy metal determination kit successfully. The first two kits includes the Cadmium and Plumbum. All of the test kits are based on Time-Resolved Fluorescence Immunochromatographic assay (TRFIA).

More Less

About us

Company details

Headquartered in Beijing since 2013, Diagreat is a high-tech enterprise specializing in developing, manufacturing and distributing of IVD (In Vitro Diagnosis) Products, which is located in Beijing Zhongguancun Science & Technology Zone.

Leading R&D technology
There is more 100 people in our R&D team, which includes 8 PHD staff and a number of Master staff who owns more than 10 patents. Our team has completed more than 50 kinds of IVD products innovation. Other than this, there are a number of products under innovation and clinical testing. The rich-experience R&D team is the base stone of Diagreat innovation.

Complete R&D Platforms
Our company consists kinds of different platforms, including Genetic engineering platform, protein expression, purification, biological enzyme preparation test platform, monoclonal antibodies, polyclonal antibody platform, nanometer microspheres, biochemical enzymes reagent R&D platform, turbidimetric reagent R&D platform, chromatography reagents development platform and homogeneous immune reagent R&D platform and so on more than 10 biochemical, immune and POCT reagents related R&D technology platform.

Multiple kinds of products
Based on the whole chain of R&D and manufacturing line, Diagreat not only focuses on the clinical IVD test, but also offers other companies technological service and provide OEM packages.

Diagreat owns a rich-experience R&D team which makes us have the ability to keep going ahead and develop new products continuously. In the quality control aspect, Diagreat obeys the rules of GMP and all of our products have been certificated by ISO9001, ISO13485 and EQA plan.
In the worldwide IVD industry, Diagreat will provide accurate and rapid IVD reagent to help clinical doctors make decision. Diagreat has been pursuing innovation, concentrating on the industry of IVD products and paying effort to become the leading supplier in IVD industry in order to create the “Diagreat” brand in the future.

 

More Less